Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value: $1.5B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BLFS | BIOLIFE SOLUTIONS INC | 8,707,165 | $218M | 14.5% | $19.43 | +21.6% | COM NEW | 09062W204 |
| RVMD | REVOLUTION MEDICINES INC | 4,114,283 | $187M | 12.4% | $25.89 | +68.2% | COM | 76155X100 |
| WGS | GENEDX HOLDINGS CORP | 3,507,164 | $149M | 9.9% | $9.11 | +270.6% | COM CL A | 81663L200 |
| LAB | STANDARD BIOTOOLS INC | 71,254,677 | $138M | 9.2% | $2.36 | -17.1% | COM | 34385P108 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,073,500 | $134M | 8.9% | $100.84 | +37.1% | COM | 803607100 |
| ILMN | ILLUMINA INC | 750,000 | $97.81M | 6.5% | $119.44 | +3.3% | COM | 452327109 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,084,841 | $95.76M | 6.4% | $14.11 | +207.6% | COM | 05370A108 |
| RLAY | RELAY THERAPEUTICS INC | 9,251,108 | $65.5M | 4.4% | $19.94 | -62.5% | COM | 75943R102 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 170,000 | $46.76M | 3.1% | $138.08 | +88.6% | COM | 02043Q107 |
| EXAS | EXACT SCIENCES CORP | 650,000 | $44.28M | 3.0% | $74.77 | -24.5% | COM | 30063P105 |
| NTLA | INTELLIA THERAPEUTICS INC | 2,000,000 | $41.1M | 2.7% | $37.51 | -38.5% | COM | 45826J105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 700,000 | $30.72M | 2.0% | $33.80 | — | SPONSORED ADS | 86366E106 |
| — | BLUEPRINT MEDICINES CORP | 326,378 | $30.19M | 2.0% | $3820.05 | — | COM | 09627Y109 |
| DNLI | DENALI THERAPEUTICS INC | 990,000 | $28.84M | 1.9% | $29.48 | -15.9% | COM | 24823R105 |
| CDXS | CODEXIS INC | 8,100,000 | $24.95M | 1.7% | $2.87 | +7.9% | COM | 192005106 |
| VCYT | VERACYTE INC | 666,308 | $22.68M | 1.5% | $24.40 | +15.3% | COM | 92337F107 |
| NGNE | NEUROGENE INC | 524,616 | $22.01M | 1.5% | $14.32 | +170.8% | COM | 64135M105 |
| — | VERVE THERAPEUTICS INC | 3,995,571 | $19.34M | 1.3% | $36.00 | — | COM | 92539P101 |
| BEAM | BEAM THERAPEUTICS INC | 775,000 | $18.99M | 1.3% | $49.33 | -47.6% | COM | 07373V105 |
| TNYA | TENAYA THERAPEUTICS INC | 6,732,971 | $12.99M | 0.9% | $12.86 | -78.1% | COM | 87990A106 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 1,150,000 | $12.43M | 0.8% | $16.94 | -2.0% | COM | 35104E100 |
| — | 2SEVENTY BIO INC | 2,000,000 | $9.44M | 0.6% | $9.15 | — | COMMON STOCK | 901384107 |
| TNGX | TANGO THERAPEUTICS INC | 1,188,349 | $9.15M | 0.6% | $5.87 | +62.5% | COM | 87583X109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 475,000 | $9.144M | 0.6% | $18.99 | +8.8% | COM | 87164F105 |
| GH | GUARDANT HEALTH INC | 350,000 | $8.029M | 0.5% | $26.87 | +5.3% | COM | 40131M109 |
| CTNM | CONTINEUM THERAPEUTICS INC | 296,666 | $5.678M | 0.4% | $16.10 | +19.1% | CL A | 21217B100 |
| IPSC | CENTURY THERAPEUTICS INC | 3,212,316 | $5.493M | 0.4% | $16.88 | -88.4% | COM | 15673T100 |
| GRAL | GRAIL INC | 350,000 | $4.816M | 0.3% | $15.40 | -1.6% | COM | 384747101 |
| ABSI | ABSCI CORPORATION | 973,260 | $3.718M | 0.2% | $19.41 | -79.5% | COM | 00091E109 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,035,859 | $1.761M | 0.1% | $11.43 | -85.6% | COM | 69404D108 |
| PRME | PRIME MEDICINE INC | 367,175 | $1.421M | 0.1% | $18.06 | -74.4% | COM | 74168J101 |
| — | EXSCIENTIA PLC | 213,900 | $1.044M | 0.1% | $19.76 | — | ADS | 30223G102 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 86,014 | $456K | 0.0% | $20.37 | -75.2% | COM | 61225M102 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 36,493 | $297K | 0.0% | $10.02 | 0.0% | CL A NEW | 37611X209 |
| — | KRONOS BIO INC | 123,839 | $124K | 0.0% | $29.87 | — | COM | 50107A104 |